StemCyte International Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2013	FY 2012
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Market Capitalization	5,383	8,059	-	-	-	-
Enterprise Value	3,541	7,099	-	-	-	-
Last Close Price	28.00	42.30	-	-	-	-
PS Ratio	13.98	21.06	-	-	-	-
PB Ratio	3.11	4.14	-	-	-	-
P/TBV Ratio	3.12	4.15	-	-	-	-
EV/Sales Ratio	9.19	18.55	-	-	-	-
Debt / Equity Ratio	0.13	0.13	0.07	0.11	0.17	-
Net Debt / Equity Ratio	-1.06	-1.03	-1.32	-1.34	0.02	-0.30
Net Debt / EBITDA Ratio	9.11	8.79	5.27	3.89	-0.38	21.51
Net Debt / FCF Ratio	21.57	11.72	11.29	11.69	-0.06	3.12
Asset Turnover	-	0.14	0.21	-	0.56	0.51
Inventory Turnover	-	0.61	0.57	-	0.66	0.54
Quick Ratio	9.07	9.42	5.04	2.69	1.29	1.87
Current Ratio	10.81	11.23	6.79	4.78	4.27	4.68
Return on Equity (ROE)	-	-14.77%	-53.70%	-	-6.94%	-1.49%
Return on Assets (ROA)	-	-6.00%	-8.74%	-	-3.31%	-1.97%
Return on Capital Employed (ROCE)	-8.20%	-8.30%	-13.90%	-12.70%	-5.90%	-3.70%
Earnings Yield	-3.49%	-2.55%	-	-	-	-
FCF Yield	-1.59%	-2.13%	-	-	-	-
Buyback Yield / Dilution	-24.60%	-24.91%	-3.60%	-79.13%	2.42%	-18.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.